Literature DB >> 5374285

Active mammary excretion of N4-acetylated sulphanilamide.

F Rasmussen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5374285      PMCID: PMC8741103     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


× No keyword cloud information.
  6 in total

1.  Serum and milk concentrations of several sulphonamides and their N4-acetyl metabolites following oral administration to cows.

Authors:  S Soback; U Lamminsivu; P Tapio
Journal:  Acta Vet Scand       Date:  1983       Impact factor: 1.695

2.  Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).

Authors:  M M Al-Bataineh; D Van Der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2011-05-30       Impact factor: 1.786

3.  The metabolism of four sulphonamides in cows.

Authors:  P Nielsen
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

Review 4.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

5.  Cultured mammary epithelial monolayers (BME-UV) express functional organic anion and cation transporters.

Authors:  M M Al-Bataineh; D van der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2009-10       Impact factor: 1.786

Review 6.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Authors:  D C Dorman; S L Allen; J Z Byczkowski; L Claudio; J E Fisher; J W Fisher; G J Harry; A A Li; S L Makris; S Padilla; L G Sultatos; B E Mileson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.